Novel advances in targeted drug delivery. - Wikidata - wikimedia - TriplyDB

Novel advances in targeted drug delivery.

Novel advances in targeted drug delivery.

http://www.wikidata.org/entity/Q50220612

about

Adverse reactions of sorafenib, sunitinib, and imatinib in treating digestive system tumors.

P2860

Q54119475-5D66F3F4-858F-4664-822C-40894054316B

P2860

Novel advances in targeted drug delivery.

http://www.wikidata.org/entity/Q50220612

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Novel advances in targeted drug delivery.

@en

Novel advances in targeted drug delivery.

@nl

type

label

Novel advances in targeted drug delivery.

@en

Novel advances in targeted drug delivery.

@nl

prefLabel

Novel advances in targeted drug delivery.

@en

Novel advances in targeted drug delivery.

@nl

P1433

Q50220612-0BDCAD22-4E11-42EA-A0DE-00979ABA3226

P1476

Q50220612-87202FEA-1E17-4A22-AA60-3DB7D6D61DDE

P2093

Q50220612-829D55AC-7D8A-405A-BD25-EBADEC4DDD2F

Q50220612-8F841138-8B54-482A-A725-D9605FA5FA1B

Q50220612-EE701E13-C487-4F06-B7AF-DFAD5D5E095C

P2860

Q50220612-0414A575-A308-4D1F-9502-AD3D9318E9F9

Q50220612-04A3321B-E82A-447E-A1AD-96B6C2DED615

Q50220612-0A7948D6-D1F3-46A0-AEB1-63E8F2D499F8

Q50220612-0AD9FFC4-53F1-4B16-B0B6-F91EEFFDED37

Q50220612-12926037-0FDB-40E9-91C2-036851B98791

Q50220612-173B77C1-4114-4154-8CB3-CC3347D9BA2E

Q50220612-1EF2B110-10D9-49A2-90C7-ECDDB9745851

Q50220612-247EB408-72DD-47AD-ACFF-DA22278B670B

Q50220612-304BA509-80FE-4864-8A24-F343BFBEC64B

Q50220612-3EA2C542-80D4-4640-87D3-9824375CD89D

P304

Q50220612-2AC2F8DE-6439-4861-805E-70ED5DE6627C

P31

Q50220612-5F10DA89-D818-4683-969C-521B31B869BA

P356

Q50220612-CCBAA288-4B41-423B-9196-1CBAC409ACC3

P577

Q50220612-78A19FC2-2B29-4AD2-8D00-CD64ED64DEBD

P698

Q50220612-E3E13B67-3FA9-43AC-A6F1-6D7ADEB3BCAD

P921

Q50220612-6CAAB18C-D5FC-48BA-B92D-A94113918FE4

P356

1061186X.2017.1401076

P1433

Journal of Drug Targeting

P1476

Novel advances in targeted drug delivery.

@en

P2093

Hakan Eroğlu

http://www.w3.org/2001/XMLSchema#string

Kıvılcım Öztürk-Atar

http://www.w3.org/2001/XMLSchema#string

Sema Çalış

http://www.w3.org/2001/XMLSchema#string

P2860

Advances and Challenges of Liposome Assisted Drug Delivery

Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues

Nanoparticle therapeutics: an emerging treatment modality for cancer

A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS.

Recent trends in targeted anticancer prodrug and conjugate design.

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.

Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.

P304

1-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1061186X.2017.1401076

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29096554

http://www.w3.org/2001/XMLSchema#string

P921